United Kingdom · Question · Written question
HL HL4680
Nirsevimab
Introduced
11 January 2023
Last action
19 January 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
19 January 2023
Summary
To ask His Majesty's Government what assessment they have made of the monoclonal antibody Nirsevimab, which was approved by the Medicines and Healthcare products Regulatory Agency in November 2022; and when it will be made available to patients on the NHS
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 January 2023
Written question
To ask His Majesty's Government what assessment they have made of the monoclonal antibody Nirsevimab, which was approved by the Medicines and Healthcare products Regulatory Agency in November 2022; and when it will be made available to patients on the NHS
Source: Lords
19 January 2023
Answer
The Joint Committee on Vaccination and Immunisation (JCVI) is actively reviewing new and emerging products to provide immunisation against Respiratory Syncytial Virus, including the monoclonal antibody Nirsevimab. Once the JCVI concludes their review of e...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-01-11/HL4680
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1566211
- uk · wq-1566211 · source updated 19 January 2023